The American Society of Clinical Pathology Quality Management Practice Review Committee is sponsoring publication of a series of articles commenting on procedures used by pathologists during the examination of various surgical specimens. Committee-sponsored survey results serve as the basis for discussion and commentary by an expert in the field. Although this information may prove useful in forming a pracQuality in the practice of anatomic pathology is a facet of patient care that is most visible in the surgical pathology report. To address this issue, the Quality Management Practice Review Committee of the ASCP has designed a process that: (1) samples the current practice of pathology for single organs through a survey of a broad spectrum of practitioners; (2) analyzes the results in consultation with a group of knowledgeable pathologists, including at least one individual recognized for special expertise in the area; and (3) provides a commentary composed by the expert under the critical direction of the group. The resulting documents are intended to inform and guide rather than direct those who must evaluate any particular organ in the practice of surgical pathology.
The ASCP Survey on Surgical Pathologic Examination of the Urinary Bladder indicates a very high level of practice among the responders. Tissue specimens of urinary bladder are received in three basic forms: cystectomy (total, radical and occasionally partial), transurethral resection (TURB), and biopsy. Urinary cytology should be added to these forms. Most biopsy and cytology specimens are collected for diagnosis or monitoring of patients with a clinical suspicion of neoplasia. Almost all TURBs and cystectomies are submitted for evaluation of established cancers. Therefore, the following discussion primarily applies to pathological examination of bladder neoplasms, recognizing that special circumstances may exist for evaluating samples submitted for other reasons.
The rationale for many "standard" methods of examination, interpretation, and reporting has not been supported by rigorous studies. These approaches have been adopted largely through custom. Many are of questionable value in the management of patients. Among those of questionable value are specimen weight, tumor configuration, determination of angiolymphatic invasion, substaging on the basis of muscularis mucosae, and the significance of intraepithelial abnormalities. As studies addressing the validity of certain customary approaches are performed, alterations in our recommendations will be required.
It is important to record the amount of tissue received, perhaps primarily as a correlation to the amount submitted. This can be done either by counting the number of specimens in each sample container, measuring the specimens, or weighing them. With the possible exception of TURBs, the weight of the specimen has little bearing on clinical management. Number of Surgical Specimens (per year) <2,500 2,500 to 5,000 5,000 to 10,000 10,000 to 20,000 >20,000 9% 20% 30% 35% 6%
AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Special Article
Classification of transitional cell neoplasms according to their growth pattern (papillary or solid) offers very little useful information for patient care so long as it is understood that neither papillary nor solid urothelial neoplasms are currently classed as in situ lesions. 2 ' 5, 6 The distinction has been widely applied only to transitional cell neoplasms and may originate from a time when in situ lesions were defined as both papillary and flat, and carcinoma in situ as a distinct entity had not been well established. All papillomas and grade 1 transitional cell tumors are papillary. Depending on the classification system used, almost none of these tumors are invasive. Therefore, the designation "papilloma" or "transitional cell carcinoma grade 1" defines a papillary lesion. In contrast, the majority of true transitional cell carcinomas are solid, at least in their invasive components. Many pathologists prefer to add the term "papillary" to low grade transitional cell neoplasms. However, stage for stage, the addition of "papillary" or "solid" adds little information not conveyed by the designation of grade alone. For example, a non-invasive, grade II or III transitional cell carcinoma (WHO system) must be papillary. A non-papillary, noninvasive lesion of this cytologic grade would be classified as a carcinoma in situ. Likewise, there is little evidence of prognostic differences between high grade invasive lesions with papillary components and similar tumors with solid components, as long as these lesions are matched for pathologic stage. 5 Grading of non-transitional cell neoplasms has not been widely accepted among pathologists. Adenocarcinomas, squamous cell carcinomas, mixed epithelial malignant neoplasms, and sarcomas tend to be aggressive, even when apparently welldifTerentiated. One might reason that bladder tumors that recapitulate colonic mucosa, skin, or soft tissue are poorly differentiated by definition.
Angiolymphatic invasion is extremely difficult to assess accurately unless observations are confined to vessels with muscular walls. For example, the spaces underlying the urothelium may not be vascular, as evidenced by studies using antibodies to endothelial antigens. 9 Several knowledgeable pathologists have found that blood vessel invasion is unusual in patients with low grade tumors, and almost always occurs in association with other poor prognostic indicators such as invasion of the detrusor muscle.
The muscularis mucosae ordinarily is represented by irregularly arranged, angulated, wispy groups of muscle fibers within the lamina propria. In the human urinary bladder, these muscle fibers are rarely sufficiently well-developed to form an anatomical barrier separating a lamina propria from a submucosal The thick-walled blood vessels appearing in this area often are not in the same plane as the muscle fibers, and can be used as a substitute landmark only in the most general sense. The orientation of most specimens, especially those with invasive cancers, may not allow such a finely tuned interpretation of depth of invasion.
Urologists have learned by empirical observation that transitional cell neoplasms not invading the muscular wall at initial diagnosis are amenable to bladder sparing treatments and may identify patients at decreased risk for an adverse outcome. They refer to such lesions, regardless of configuration, grade, or presence of lamina proprial invasion as "superficial bladder tumors." A statement of the presence of muscular wall (detrusor) tissue in the specimen is important to urologists, and must be reported even if the muscle is not invaded by the tumor. 14 Intraepithelial abnormalities with cytological features resembling those of bladder neoplasms (dysplasia/atypical hyperplasia) should be noted, but the clinical importance of this information is not completely clear. Intraepithelial lesions are best examined using fixatives that preserve the greatest amount of nuclear detail. Bouin's-type fixatives are optimal, but tissues exposed to these solutions cannot be subsequently examined by electron microscopy, and are suboptimal at best for flow cytometry. 12 Zinc formalin produces specimens with sufficient nuclear detail for adequate analysis by those methods. Phosphate buffered formalin is acceptable, but special attention should be paid to maintaining a constant pH of 6.8 to 7.0 in the solution. The lowest grade of intraepithelial lesions (simple hyperplasia, dysplasia, atypical hyperplasia) is difficult to define and recognize. The highest grade lesions (CIS) are easily seen, but usually accompany high-grade invasive tumors known to have a poor prognosis anyway. A flat intraepithelial lesion with cytologic features identical to those of a contiguous papillary or invasive neoplasm should be considered part of the tumor rather than a separate neoplasm. In contrast, similar intraepithelial abnormalities occurring at non-contiguous sites should be recorded separately according to their cytological severity as dysplasia (atypical hyperplasia) or CIS. A severely dysplastic lesion separate from CIS has not been defined as an entity with distinctive clinical or pathological features in the urinary bladder. 11 A full thickness change such as required by the 1961 Congress on Uterine Cervical Lesions is not necessary to recognize CIS in the urothelium.
Urinary cytology is essential to accurate detection and monitoring of patients with bladder neoplasms. 8, 11 It is especially useful in cases of carcinoma in situ and in patients treated with topical therapy. It is the only reliable method to monitor patients with intestinal conduits, and will become important to the assessment of the increasing number of individuals with "intestinal neobladders" connected to their residual urethras. Many, if not most, pathologists involved in examining specimens from bladder cancer patients routinely evaluate urinary samples. This type of specimen should be an integral part of any commentary on bladder specimen examination.
CYSTECTOMY
These specimens almost always include the entire urinary bladder and contiguous pelvic structures such as segments of ureters and paravesical fat. In women, the entire urethra is ASCP Survey included. In men, a segment of urethra is usually included, although some surgeons resect the entire organ. The prostate gland, seminal vesicles, and segments of vasa deferentia also are included in specimens from men. Most surgeons will have separately submitted portions of distal ureters for frozen section examination to ensure adequacy of resection, so that the ureteral margins in the cystectomy specimen will not represent the actual distal margins. The urethral margin is generally distinct. Except in unusual circumstances, specimens need not be inked.
Partial cystectomies are almost always composed only of urinary bladder. Although not addressed in the survey, they can be evaluated using the same principles. Full thickness sections from the lateral margins of these wedge-shaped specimens, embedded so as to section the specimen margin (after minimal facing of the block) are recommended. 
Gross Inspection and Processing
%
COMMENTARY
There is remarkable uniformity in the methods by which pathologists inspect and process cystectomy specimens. A method worth considering, but not widely used, involves inflating the bladder with formalin, fixing overnight, and bivalving the specimen in the frontal plane. The preferred method can be summarized as follows:
• Open specimen along the anterior mid-line, creating angular cuts at the dome if necessary to pin the specimen flat; • Measure specimen, including lengths of ureteral segments and urethra (do not probe urethra or ureters for identification; look for ties or clips on ureters); • Remove paravesical fat and search for lymph nodes (there are rarely more than 2 or 3); • Record any urothelial abnormalities (erythema, surgical resection ulcers, tumors) but do not rub the mucosa; • Pin bladder and associated tissue flat and fix overnight. 
Sectioning
COMMENTARY
Almost all pathologists routinely submit sections to fully evaluate tumors and their invasiveness. They are also interested in the urethral and ureteral margins. There is considerably less agreement regarding the number of sections required to adequately characterize the tumor and the sampling of preselected sites of apparently normal mucosa. Estimations of volume of neoplastic tissue at specimen margins are apparently not attempted. Given the complexity of a cystectomy specimen and the variety of abnormalities that might occur, it seems reasonable to take the following sections ( Fig. 1): • Margins of ulcers or tumors at 1 section per cm diameter of lesion (full thickness); • Sections through the deepest portions of ulcers or tumors (full thickness); • Sections from mottled or erythematous areas of mucosa (need not be full-thickness, but should include bladder wall); • Representative sections from grossly normal mucosa at the dome, lateral walls, trigone (need not be full-thickness); • The distal urethra (this is best accomplished by amputating the distal urethra at a point approximately 1 cm from the surgical margin and creating vertical sections from this piece, so that the distal surgical margin will have been sampled at multiple right angle sites; a portion of the underlying prostate gland in men tends to stabilize the sections in the embedding process and reveals tumor involvement of periurethral ducts and should be included);
• Transections of distal, mid-portions, and intramural portions of ureters; • Representative sections of prostate gland (if present) to include any grossly visible lesions, and any portion of the periurethral part of the gland not previously included in the sections of urethral margin; • Representative sections of seminal vesicles and vasa deferentia.
In most cases, the entire cystectomy specimen can be included in less than 25 blocks. A reasonable attempt should be made to identify intramucosal abnormalities, but several studies have already indicated that intraepithelial dysplasia/CIS occurs in essentially every case if diligently sought. It is not necessary to reconfirm this in every case. 3 Widespread intramucosal disease will be sampled with the recommended techniques and should be recorded, because it might have prognostic importance. If prostate glands are serially sectioned, 40% to 50% will contain areas of adenocarcinoma. 10 These carcinomas are usually low grade and low stage. There is no evidence that their presence affects overall prognosis. The prognostic importance of transitional cell carcinoma in the prostate gland is more controversial.
1317 Many experts consider prostatic involvement to be evidence of a high stage tumor whereas others believe that prostatic involvement is only important if the tumor has invaded the stroma. If the distal urethra is sectioned according to the method above, a great deal of prostatic tissue will be included. Gross inspection of the prostate can identify large tumors in the majority of instances. Given the available data, it 
Microscopic Evaluation
Survey Information
Classify tumor according to growth pattern (eg, papillary, non-papillary, etc.) Classify tumor according to histologic cell type (eg, transitional cell, adenocarcinoma, etc.) Assign grades, specifying the grading system: 1 to 2 grade system (low-
COMMENTARY
Classification of neoplasms according to their depth of invasion, dissemination (if known), and degree of cytologic anaplasia is standard procedure for most pathologists. In organs lined by urothelium, most pathologists also evaluate the grossly unremarkable mucosa. Microscopic evaluation should include observations of the following:
• Pathologic abnormalities and their sites of origin, including non-neoplastic abnormalities such as previous surgical sites; • The histologic type, grade (TCC only), and depth of invasion of neoplasms; • The presence or absence of angiolymphatic invasion, realizing that many subepithelial spaces are not true vessels; • Specimen margins (distal ureters, urethra and the soft tissue margin) overlying the tumor/surgical resection site; • Abnormalities in contiguous organs.
The lack of uniformity in grading bladder neoplasms is not surprising. Almost all pathologists agree that grading of transitional cell neoplasms is important as an indicator of future behavior. There are several grading systems in current use. With notable exceptions, the histologic criteria by which any individual tumor could be classified into any particular grade have not been well established in the literature." A certain amount of intra-and interobserver variability can be expected when systems are poorly defined, or when multiple variables must be considered. Given these problems, a surprising degree of uniformity in approach, if not in nomenclature, occurs for transitional cell neoplasms. Many clinicians and pathologists recognize that the lowest grade tumors are histologically and cytologically benign even though they are associated with a high frequency of new tumors arising in the bladder. Many clinicians and pathologists also agree that the potential for aggressive behavior is proportional to the degree of cellular anaplasia. 5 
The majority of responders comment on the most important features of neoplastic conditions.
The pathology report for a cystectomy should include the following:
• A list of all pathologic abnormalities expressed in diagnostic terms; • The histological type, grade (TCC only), depth of invasion (lamina propria, inner half of muscular wall, outer half of muscular wall), and presence of angiolymphatic invasion of neoplasms; • A statement regarding involvement of contiguous organs and tissues, such as prostate gland and paravesical fat. In the case of prostatic tissue, distinction between ductal and stromal involvement; • A record of the extent of intraepithelial abnormalities (ie, whether focal or multifocal). If intraepithelial abnormalities (dysplasia/CIS) are contiguous with a papillary or invasive neoplasm, and are of the same degree of cytologic anaplasia, only one diagnosis is necessary. If intraepithelial abnormalities (dysplasia/CIS) are not contiguous with a papillary or invasive neoplasm, or are of significantly different degrees of anaplasia, a separate diagnosis is indicated. Communication with clinicians is greatly facilitated if the grading scheme used is included on the report. This can be easily accomplished by noting the scheme, such as WHO, AshBroders, Bergkvist, etc., beside the numerical classification (ie, WHO I/III, Ash-Broders 2/4, Bergkvist 3/4. The author's personal grading preference is detailed elsewhere." Information regarding staging (ie, extent of invasion, lymph node metastases, and dissemination to distant sites), should be recorded. It can be communicated directly using the UICC/AJCC system or indirectly through inclusion of this information in a note or description included in the pathology report. 4 
TRANSURETHRAL RESECTIONS
Transurethral resections (TURBs) are almost always removed from patients with highly suspicious lesions or pathologically proven carcinomas. Orientation is often a problem, especially in the evaluation of muscle invasion. Collagenous tissue may be abundant and may be mistaken for muscle. 
Microscopic Evaluation Gross Inspection and Processing
Survey Information
COMMENTARY
Responding pathologists attempt to classify bladder neoplasms according to the information included in the section on cystectomy. Almost three fourths are able to identify the muscularis mucosae as a tissue component distinct from muscularis propria. Because the muscularis mucosae usually is poorly developed in humans and the thick-walled blood vessels that occupy the lamina propria tend not to occur in a uniform plane, it is difficult to recommend using the muscularis mucosae to divide subepithelial connective tissue into two layers: lamina propria and submucosal Most pathologists recognize that not all TURBs are performed for neoplastic disease. The recommended approach to microscopic evaluation of TURBs is summarized as follows:
Identify pathological abnormalities; Observe the extent of the abnormalities; Observe type, grade, and depth of invasion of neoplasms; Observe the presence of fat (fat may occur within the bladder and does not always indicate transmural transgression).
Most pathologists record some measure of the amount of specimen received. The specimen is usually small enough to be entirely embedded for microscopic examination. Fat is not uncommon in TURBs. It may be paravesical or part of the lamina propria or even muscularis propria. An accurate distinction is not always possible. The usual method of inspection and processing can be summarized as follows: Weigh specimen; Record greatest dimensions of largest and smallest pieces (aggregate dimensions depend on how tightly the examiner compresses the tissue and are less reliable than a combination of weight and measurement); Sample generously; in most cases the entire specimen can be embedded in less than 10 cassettes; Bouin's-type fixatives may not be optimal for large specimens; zinc formalin is preferable to phosphate buffered formalin. formalin; either is preferable to phosphate buffered formalin; • Section at multiple levels; two sections at each of three levels should suffice.
Microscopic Evaluation
Survey Information
Classify 
EXAMINATION A N D REPORTING OF BLADDER BIOPSIES
Bladder biopsies are usually obtained with "cold cup" forceps, which yield a small portion of tissue that curls into a ball in the fixative. Orientation is not a significant problem. Depending on size, specimens can be bisected before embedding.
Gross Inspection and Processing
Survey Information
Record measurements of specimen Record weight of specimen Embed entire specimen Embed representative portion of specimen If specimen is small, section the block at multiple levels The approach to bladder biopsies is similar to that for TURBs, but differs in two important respects: biopsies are not always performed for evaluation of neoplasms, and intramucosal abnormalities more often are the focal point for interpretation. Being small, these biopsies are amenable to fixation in solutions with poor penetrating qualities, such as Hollande's. 12 The recommended procedure can be summarized as follows:
COMMENTARY
• Record number of specimens; • Measure the largest and smallest specimen and record in terms of greatest dimension of each; • Fix in a Bouin's-type solution, such as Hollande's, or in zinc In contrast to other types of bladder specimens, epithelial denudation is often a prominent feature in biopsy specimens. When present, significant denudation should be noted because intramucosal abnormalities cannot be adequately interpreted. Responding pathologists evaluate biopsies in a fashion similar to TURBs. Their approach includes the identification of any pathologic alteration, and a notation of the presence of portions of muscular wall. 
Reporting
COMMENTARY
As reflected in the survey data, bladder neoplasms may be evaluated using a variety of techniques not readily available to most laboratories. They include tests for antigenic composition, DNA pioidy, cellular kinetics, genetic constitution, gene regulation, and protein production using methods such as flow and image cytometry, in situ and fluorescence in situ hybridization, silver impregnation, and direct chromosomal observation."
These special techniques can be valuable in clinical practice under certain circumstances, such as DNA pioidy in urinary cytology. They are not currently of proven value as routine tests. The lack of standardized methodology and methods of reporting should not necessarily be a deterrent, especially because such standards are lacking for the evaluation of most tissues using standard light microscopy. For many laboratories, the clinical value of adjunctive techniques, such as DNA pioidy for grading tissue specimens or detecting neoplastic cells in urinary cytology, has been in inverse relation to the institution's diagnostic success using criteria developed for light microscopy.
The majority of adjunctive techniques are currently applied to bladder specimens in research settings. The most widely used method in patient care situations is cytometry (image or flow) for DNA pioidy. Assessment of DNA pioidy on bladder specimens has significantly increased the diagnostic yield primarily in those laboratories having limited success in the application of light microscopic criteria to urinary specimens, and for those using the WHO classification scheme, where the criteria for each individual grade are vague."' 4 ' 6 Assessment of pioidy is especially valuable when used as an integral part of the pathologic evaluation of bladder specimens, in conjunction with light microscopic examination of histologic or cytologic samples. Ideally, interpretations of adjunctive tests should be included as part of the surgical or cytopathology report rather than as a separate document. When special techniques are used in a diagnostic setting, the pathologist should comment on the method used as well as interpreting the results.
ITEMS NOT ADDRESSED IN THE SURVEY
Urinary Specimens
Cytologic sampling of the urinary bladder constitutes a type of specimen that should be included in any survey of the current practice of pathology in this area. Urinary specimens may include randomly voided urine, catheterized urine, or bladder washings. All can be examined using the same cytologic criteria. These criteria have been detailed and illustrated in the literature. 8 " Urinary cytology samples more of the urothelium than can be sampled with biopsies and the results may or may not correlate. Almost all true carcinomas can be detected using this method, especially if multiple samples are obtained. Persistent or recurrent bladder carcinoma can be detected using urinary cytology when lesions are not visible cystoscopically.
Gross Inspection And Processing
• Record amount and color of specimen; • Preserve specimen to inhibit bacterial overgrowth and cellular degeneration; refrigeration is satisfactory, but dilute alcohol solutions may also be used; • Process as soon as possible, ideally within 4 hours; • Process using usual techniques (in most laboratories, the cytocentrifuge is used but membrane filter preparations are equally good); • Stain in such a way as to optimize nuclear detail (EA50 is preferred but other stains are adequate).
Microscopic Evaluation And Reporting
• Report the presence of normal, dysplastic (atypical), suspicious, and malignant cells (almost all malignant cells will be epithelial and most will be of high cytologic grade, but some low grade neoplasms can also be identified cytologically). Malignant cells can be graded, but it should be emphasized ASCP Survey that correlations above that achieved by statistics alone (90% of malignant neoplasms will be transitional cell) probably cannot be achieved, and neoplasms cannot be localized by cytology; carcinoma in situ cannot be reliably distinguished from invasive carcinomas of similar cytologic grade.
